Latest Breaking News On - Precision pairing - Page 2 : comparemela.com

Medigene AG Secures European Patent for its PD1-41BB Costimulatory Switch Protein

Medigene AG Secures European Patent for its PD1-41BB Costimulatory Switch Protein
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesPamela keckPlanegg martinsriedDoloresj schendelHongsheng sciencesEuropean patent officeEuropean patentPrime standardHelmholtz munichEnd to platformSwitch proteinsPrecision pairingCellular oncologyProgrammed death ligand

Medigene AG Announces Lead Selection for MDG2011 Representing the First TCR-T Therapy of its KRAS Library

Medigene AG Announces Lead Selection for MDG2011 Representing the First TCR-T Therapy of its KRAS Library
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Planegg martinsriedPamela keckHongsheng sciencesLead selectionPrime standardChief executive officerSwitch proteinsPrecision pairingProgrammed death ligand

Medigene presents rationale for combining its 3S TCRs with enhancement tools as an approach to improve clinical outcomes

Medigene presents rationale for combining its 3S TCRs with enhancement tools as an approach to improve clinical outcomes
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Pamela keckDolores schendelHongsheng sciencesPrime standardChief scientific officerSwitch receptorsDolores schendel chief scientific officerEnd to platformPrecision pairingProgrammed death ligand

Medigene presents rationale for combining its 3S TCRs with enhancement tools as an approach to

Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard) is an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors. Prof. Dolores

Pamela keckDolores schendelHongsheng sciencesPrime standardChief scientific officerSwitch receptorsDolores schendel chief scientific officerEnd to platformPrecision pairingSwitch proteinProgrammed death ligandSci advisors

Medigene presents rationale for combining its 3S TCRs with enhancement tools as an approach to improve clinical outcomes

Medigene presents rationale for combining its 3S TCRs with enhancement tools as an approach to improve clinical outcomes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Dolores schendelPamela keckHongsheng sciencesPrime standardChief scientific officerSwitch receptorsDolores schendel chief scientific officerEnd to platformPrecision pairingProgrammed death ligand